Dashboard
1
With ROE of 7.62%, it has a attractive valuation with a 0.43 Price to Book Value
- Over the past year, while the stock has generated a return of -3.06%, its profits have fallen by -24.1%
- At the current price, the company has a high dividend yield of 5.8
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,211 Million (Micro Cap)
6.00
NA
3.84%
-0.13
7.62%
1.07
Revenue and Profits:
Net Sales:
438 Million
(Quarterly Results - Jun 2026)
Net Profit:
29 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.18%
0%
11.18%
6 Months
6.12%
0%
6.12%
1 Year
20.39%
0%
20.39%
2 Years
-11.05%
0%
-11.05%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Shandong Sinoglory Health Food Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.43%
EBIT Growth (5y)
2.66%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
1.36
Tax Ratio
23.41%
Dividend Payout Ratio
86.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.28%
ROE (avg)
9.43%
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.43
EV to EBIT
3.14
EV to EBITDA
2.37
EV to Capital Employed
0.34
EV to Sales
0.23
PEG Ratio
NA
Dividend Yield
5.79%
ROCE (Latest)
10.95%
ROE (Latest)
7.62%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
438.40
333.50
31.45%
Operating Profit (PBDIT) excl Other Income
58.30
51.70
12.77%
Interest
0.20
0.20
Exceptional Items
0.00
0.00
Consolidate Net Profit
29.40
26.60
10.53%
Operating Profit Margin (Excl OI)
93.20%
102.00%
-0.88%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 31.45% vs -13.96% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 10.53% vs 0.00% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,384.80
1,486.60
-6.85%
Operating Profit (PBDIT) excl Other Income
187.70
157.60
19.10%
Interest
0.70
1.10
-36.36%
Exceptional Items
0.00
0.00
Consolidate Net Profit
94.70
109.10
-13.20%
Operating Profit Margin (Excl OI)
84.70%
83.70%
0.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -6.85% vs -12.21% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -13.20% vs -0.91% in Dec 2024
About Shandong Sinoglory Health Food Co. Ltd. 
Shandong Sinoglory Health Food Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






